1.Difference in action sites between mecamylamine and hexamethonium on nicotinic receptors of sympathetic neurons.
Wei LIU ; Jian-Quan ZHENG ; Zhen-Wei LIU ; Li-Jun LI ; Qin WAN ; Chuan-Gui LIU
Acta Physiologica Sinica 2002;54(6):497-500
To compare the difference in action sites between mecamylamine (MEC) and hexamethonium (HEX) on nicotinic receptors of sympathetic neurons, we investigated the effects of MEC and HEX on the nicotine-induced currents in cultured superior cervical ganglion neurons by whole-cell patch clamp technique. The IC(50) of MEC and HEX for antagonizing the effect of 0.08 mmol/L nicotine was 0.0012 and 0.0095 mmol/L, respectively. Both MEC and HEX accelerated the desensitization of nicotinic receptors. Furthermore, by comparing their effects at holding potentials 30, 70 and 110 mV, it was indicated that their suppressing effect on the nicotine-induced currents was voltage-dependent. However, different from that of HEX, the inhibitory effect of MEC increased with administering the mixture of MEC and nicotine at intervals of 3 min, indicating a use-dependent effect of MEC. It is concluded that the action site of MEC on nicotinic receptors of sympathetic neurons is different from that of HEX.
Animals
;
Animals, Newborn
;
Cells, Cultured
;
Hexamethonium
;
pharmacology
;
Mecamylamine
;
pharmacology
;
Neurons
;
drug effects
;
physiology
;
Nicotinic Antagonists
;
pharmacology
;
Patch-Clamp Techniques
;
Rats
;
Rats, Wistar
;
Receptors, Nicotinic
;
drug effects
;
physiology
;
Superior Cervical Ganglion
;
cytology
;
physiology
2.Effect of Spinal Adrenergic and Cholinergic Antagonists for Antinociception of Intrathecal Gabapentin.
Myung Ha YOON ; Sung Su CHUNG ; Hyeong Seok KIM
Korean Journal of Anesthesiology 2002;42(5):677-684
BACKGROUND: Intrathecal gabapentin is effective on nociceptive states evoked by tissue injury. In addition, gabapentin interacts synergistically with clonidine at the spinal level, suggesting that a mechanism of gabapentin may be related to spinal adrenoceptors. However, it has not been established whether this drug is associated with cholinergic receptors. The aim of this study was to examine the role of spinal adrenergic and cholinergic receptors on the antinociceptive action of intrathecal gabapentin. METHODS: Rats were implanted with lumbar intrathecal catheters. For a nociceptive test, 50nl of 5% formalin solution was injected into the hindpaw. The effect of intrathecal gabapentin, administered 10 min before the formalin injection, was assessed. Next, antagonistic effects of intrathecal prazosin, yohimbine, atropine and mecamylamine for the action of intrathecal gabapentin were evaluated. RESULTS: Formalin injection caused a biphasic incidence of flinching of the injected paw. Intrathecal gabapentin produced a dose-dependent suppression of only the phase 2 flinching response in the formalin test. Intrathecal atropine, but not prazosin, yohimbine nor mecamylamine, reversed the antinociception of intrathecal gabapentin. CONCLUSIONS: The antinociceptive effect of intrathecal gabapentin on facilitated states may be mediated through the muscarinic receptor but by neither the nicotinic receptor nor the adrenergic receptor at the spinal level.
Animals
;
Atropine
;
Catheters
;
Cholinergic Antagonists*
;
Clonidine
;
Formaldehyde
;
Incidence
;
Mecamylamine
;
Nociception
;
Pain Measurement
;
Prazosin
;
Rats
;
Receptors, Adrenergic
;
Receptors, Cholinergic
;
Receptors, Muscarinic
;
Receptors, Nicotinic
;
Spinal Cord
;
Yohimbine
3.The Regulation of AP-1 DNA Binding Activity by Long-term Nicotine Stimulation in Bovine Adrenal Medullary Chromaffin Cells: Role of Second Messengers.
Jin Koo LEE ; Seong Soo CHOI ; Hong Won SUH
The Korean Journal of Physiology and Pharmacology 2002;6(2):109-112
The signal pathways involved in the regulation of AP-1 DNA binding activity in long-term nicotine stimulated bovine adrenal medullary chromaffin (BAMC) cells have not been well characterized. To understand the involvement of second messengers in the regulation of AP-1 DNA binding activity, the present study was designed to define the time-course for inhibition of nicotine-induced responses by cholinergic antagonists, Ca2+ and calmodulin (CaM) antagonists, and calcium/calmodulin-dependent protein kinase (CaMK) II inhibitor using electrophoretic mobility shift assay. Nicotine (10microM) stimulation increased AP-1 DNA binding activity at 24 hr after treatment. Posttreatment with hexamethonium (1 mM) plus atropine (1microM) (HA), nimodipine (1microM), or calmidazolium (1microM) at 0.5, 3, and 6 hr after the nicotine treatment significantly inhibited the AP-1 DNA binding activity increased by long-term nicotine stimulation. However, posttreatment with HA, nimodipine, or calmidazolium at 9 or 12 hr after the nicotine treatment did not affect the nicotine-induced increase of AP-1 DNA binding activity. The pretreatment of BAMC cells with various concentrations of KN-62 inhibited the increase of AP-1 DNA binding activity induced by nicotine in a concentration-dependent manner. KN-62 (10microM) posttreatment beginning at 0.5, 3, or 6 hr after the nicotine treatment significantly inhibited the increase of AP-1 DNA binding activity. However, KN-62 posttreatment beginning at 9 or 12 hr after the nicotine treatment did not affect the increase of AP-1 DNA binding activity. This study suggested that stimulation (for at least 6 hr) of nicotinic receptors on BAMC cells was necessary for increase of AP-1 DNA binding activity, and activation of Ca2+, CaM, and CaMK II up to 6 hr at least seemed to be required for the increase of nicotine-induced AP-1 DNA binding activity.
Atropine
;
Calmodulin
;
Cholinergic Antagonists
;
Chromaffin Cells*
;
DNA*
;
Electrophoretic Mobility Shift Assay
;
Hexamethonium
;
Nicotine*
;
Nimodipine
;
Protein Kinases
;
Receptors, Nicotinic
;
Second Messenger Systems*
;
Signal Transduction
;
Transcription Factor AP-1*
4.Roles of ACh receptors in the effects of corticosterone on presympathetic neurons in the ventrolateral medulla of rats.
Wei-Zhong WANG ; Xue-Mei WANG ; Wei-Fang RONG ; Ji-Jang WANG ; Wen-Jun YUAN
Chinese Journal of Applied Physiology 2002;18(1):9-13
AIMTo investigate the roles of acetylcholine (ACh) receptors in the rapid effects of corticosterone (CORT) on the presympathetic neurons in the rostral ventrolateral medulla (RVLM) of rats, and study the non-genomic mechanism of glucocorticoid (GC) in the integration of sympathetic cardiovascular activity.
METHODSThe effects of microelectrophoresis of CORT on the discharge of the presympathetic neurons in the RVLM were observed by extracellular recording in urethane-anaesthetized rats. The responses of atropine (a blocker for M type of ACh receptor, ATR), d-tubocurarine (a blocker for N1 type of ACh receptor, d-TC) and hexamethonium (a blocker for N2 type of ACh receptor, C6) to the effects of CORT on the presympathetic neurons were investigated respectively.
RESULTSTotally 33 presympathetic neurons in the RVLM were recorded. Among them the firing rate of 25 (76%) presympathetic neurons was increased by microelectrophoresis of CORT. The effects of CORT were also positively correlated with the currents. In the other 8 presympathetic neurons, had was shown no effect after microelectrophoresis of CORT. In 10 presympathetic neurons, which discharge was increased by CORT, microelectrophoresis of ATR decreased the firing rate of these presympathetic neurons (P < 0.05), and did not fully block the excitatory effect induced by CORT. In both 7 and 6 presympathetic neurons, application of d-TC and C6 had no effect on these neurons respectively, and did not fully block the excitatory effect induced by CORT.
CONCLUSIONCORT had rapid excitatory effects on the presympathetic neurons in the RVLM, which effect might be independent on ACh receptors.
Animals ; Cholinergic Antagonists ; pharmacology ; Corticosterone ; pharmacology ; Electrophoresis, Microchip ; Male ; Medulla Oblongata ; drug effects ; physiology ; Neuromuscular Nondepolarizing Agents ; pharmacology ; Neurons ; drug effects ; physiology ; Nicotinic Antagonists ; pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Cholinergic ; physiology
5.Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia.
Ju Hyun MOON ; Soo Yoon KIM ; Hwan Goo LEE ; Seung U KIM ; Yong Beom LEE
Experimental & Molecular Medicine 2008;40(1):11-18
Recent studies have reported that the "cholinergic anti-inflammatory pathway" regulates peripheral inflammatory responses via alpha7 nicotinic acetylcholine receptors (alpha7 nAChRs) and that acetylcholine and nicotine regulate the expression of proinflammatory mediators such as TNF-alpha and prostaglandin E2 in microglial cultures. In a previous study we showed that ATP released by beta-amyloid-stimulated microglia induced reactive oxygen species (ROS) production, in a process involving the P2X7 receptor (P2X7R), in an autocrine fashion. These observations led us to investigate whether stimulation by nicotine could regulate fibrillar beta amyloid peptide (1-42) (fA beta(1-42))-induced ROS production by modulating ATP efflux-mediated Ca2+ influx through P2X7R. Nicotine inhibited ROS generation in fA beta(1-42)-stimulated microglial cells, and this inhibition was blocked by mecamylamine, a non-selective nAChR antagonist, and a-bungarotoxin, a selective alpha7 nAChR antagonist. Nicotine inhibited NADPH oxidase activation and completely blocked Ca2+ influx in fA beta(1-42)-stimulated microglia. Moreover, ATP release from fA beta(1-42)-stimulated microglia was significantly suppressed by nicotine treatment. In contrast, nicotine did not inhibit 2',3'-O-(4-benzoyl)-benzoyl ATP (BzATP)-induced Ca2+ influx, but inhibited ROS generation in BzATP-stimulated microglia, indicating an inhibitory effect of nicotine on a signaling process downstream of P2X7R. Taken together, these results suggest that the inhibitory effect of nicotine on ROS production in fA beta(1-42)-stimulated microglia is mediated by indirect blockage of ATP release and by directly altering the signaling process downstream from P2X7R.
Adenosine Triphosphate/analogs & derivatives/metabolism/pharmacology
;
Amyloid/*metabolism
;
Amyloid beta-Protein/*pharmacology
;
Animals
;
Calcium/metabolism
;
Enzyme Activation/drug effects
;
Microglia/cytology/*drug effects/enzymology/*metabolism
;
NADPH Oxidase/metabolism
;
Nicotine/pharmacology
;
Nicotinic Antagonists/pharmacology
;
Peptide Fragments/*pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Reactive Oxygen Species/*metabolism
;
Receptors, Nicotinic/*metabolism
;
Receptors, Purinergic P2/metabolism
6.Inhibitory Effects of Structurally Different Neuromuscular Blockers on the Serotonin Type 3 Receptor Expressed in Xenopus Oocytes.
Kyeong Tae MIN ; Yong Taek NAM ; Kyung Mee OH ; Jay YANG
Korean Journal of Anesthesiology 1999;37(2):295-302
BACKGROUND: The serotonin type 3 receptors are diffusely distributed in both the central and the peripheral nervous system. Physiological and pathophysiological processes thought to be mediated by this receptor include nausea and vomiting, peripheral nociception and central antinociception, conditioned aversion response to drugs, anxiety, and cognition. Because of the structural similarity between the nicotinic acetylcholine receptor and the 5HT3 receptor, we investigated the effects of clinically used neuromuscular blockers on the 5HT3 receptor function related with PONV. METHODS: A cDNA clone encoding the full length murine 5HT3a receptor was subcloned into an oocyte expression vector and 50 ng of cRNA transcribed in vitro injected per oocyte. After 24 72 h incubation, oocytes were placed into a recording chamber continuously perfused with frog Ringer's solution and electrophysiological recordings were obtained by the two electrode voltage clamp technique. Serotonin with or without the various drugs were bath applied by a computer controlled solenoid valve. Peak currents induced by the drug applications were measured and dose responses were obtained. RESULTS: The 5HT3 receptor expression in Xenopus oocyte was identified by the pharmacologic tools. Serotonin induced rapid inward currents, and thus was showed dose-dependent: KD = 2.5 micrometer, Hill coefficiency = 2.09. Inhibition by the neuromuscular blockers showed dose-dependence and their inhibitory potency on 5HT3 receptor (IC50) was in order of d-tubocurarine (0.046 micrometer) > vecuronium (16.32 micrometer) > gallamine (1,169 micrometer). CONCLUSIONS: There was a different inhibitory effect of nicotinic cholinergic antagonists, clinically used neuromuscular blockers, on the 5HT3 receptor and a judicious selection of them might contribute to reducing the incidence of PONV clinically.
Anxiety
;
Baths
;
Cholinergic Antagonists
;
Clone Cells
;
Cognition
;
DNA, Complementary
;
Electrodes
;
Gallamine Triethiodide
;
Incidence
;
Nausea
;
Neuromuscular Blockade*
;
Neuromuscular Blocking Agents*
;
Nociception
;
Oocytes*
;
Peripheral Nervous System
;
Postoperative Nausea and Vomiting
;
Receptors, Nicotinic
;
RNA, Complementary
;
Serotonin*
;
Tubocurarine
;
Vecuronium Bromide
;
Vomiting
;
Xenopus*
7.Inhibitory Effects of Structurally Different Neuromuscular Blockers on the Serotonin Type 3 Receptor Expressed in Xenopus Oocytes.
Kyeong Tae MIN ; Yong Taek NAM ; Kyung Mee OH ; Jay YANG
Korean Journal of Anesthesiology 1999;37(2):295-302
BACKGROUND: The serotonin type 3 receptors are diffusely distributed in both the central and the peripheral nervous system. Physiological and pathophysiological processes thought to be mediated by this receptor include nausea and vomiting, peripheral nociception and central antinociception, conditioned aversion response to drugs, anxiety, and cognition. Because of the structural similarity between the nicotinic acetylcholine receptor and the 5HT3 receptor, we investigated the effects of clinically used neuromuscular blockers on the 5HT3 receptor function related with PONV. METHODS: A cDNA clone encoding the full length murine 5HT3a receptor was subcloned into an oocyte expression vector and 50 ng of cRNA transcribed in vitro injected per oocyte. After 24 72 h incubation, oocytes were placed into a recording chamber continuously perfused with frog Ringer's solution and electrophysiological recordings were obtained by the two electrode voltage clamp technique. Serotonin with or without the various drugs were bath applied by a computer controlled solenoid valve. Peak currents induced by the drug applications were measured and dose responses were obtained. RESULTS: The 5HT3 receptor expression in Xenopus oocyte was identified by the pharmacologic tools. Serotonin induced rapid inward currents, and thus was showed dose-dependent: KD = 2.5 micrometer, Hill coefficiency = 2.09. Inhibition by the neuromuscular blockers showed dose-dependence and their inhibitory potency on 5HT3 receptor (IC50) was in order of d-tubocurarine (0.046 micrometer) > vecuronium (16.32 micrometer) > gallamine (1,169 micrometer). CONCLUSIONS: There was a different inhibitory effect of nicotinic cholinergic antagonists, clinically used neuromuscular blockers, on the 5HT3 receptor and a judicious selection of them might contribute to reducing the incidence of PONV clinically.
Anxiety
;
Baths
;
Cholinergic Antagonists
;
Clone Cells
;
Cognition
;
DNA, Complementary
;
Electrodes
;
Gallamine Triethiodide
;
Incidence
;
Nausea
;
Neuromuscular Blockade*
;
Neuromuscular Blocking Agents*
;
Nociception
;
Oocytes*
;
Peripheral Nervous System
;
Postoperative Nausea and Vomiting
;
Receptors, Nicotinic
;
RNA, Complementary
;
Serotonin*
;
Tubocurarine
;
Vecuronium Bromide
;
Vomiting
;
Xenopus*
8.Spinal Gabapentin and Antinociception: Mechanisms of Action.
Myung Ha YOON ; Jeong Il CHOI ; Seong Wook JEONG
Journal of Korean Medical Science 2003;18(2):255-261
Spinal gabapentin has been known to show the antinociceptive effect. Although several assumptions have been suggested, mechanisms of action of gabapentin have not been clearly established. The present study was undertaken to examine the action mechanisms of gabapentin at the spinal level. Male SD rats were prepared for intrathecal catheterization. The effect of gabapentin was assessed in the formalin test. After pretreatment with many classes of drugs, changes of effect of gabapentin were examined. General behaviors were also observed. Intrathecal gabapentin produced a suppression of the phase 2 flinching, but not phase 1 in the formalin test. The antinociceptive action of intrathecal gabapentin was reversed by intrathecal NMDA, AMPA, D-serine, CGS 15943, atropine, and naloxone. No antagonism was seen following administration of bicuculline, saclofen, prazosin, yohimbine, mecamylamine, L-leucine, dihydroergocristine, or thapsigargin. Taken together, intrathecal gabapentin attenuated only the facilitated state. At the spinal level, NMDA receptor, AMPA receptor, nonstrychnine site of NMDA receptor, adenosine receptor, muscarinic receptor, and opioid receptor may be involved in the antinociception of gabapentin, but GABA receptor, L-amino acid transporter, adrenergic receptor, nicotinic receptor, serotonin receptor, or calcium may not be involved.
Acetic Acids/administration & dosage
;
Acetic Acids/metabolism
;
Acetic Acids/pharmacology*
;
Adrenergic Antagonists/metabolism
;
Adrenergic alpha-Antagonists/metabolism
;
Analgesics/administration & dosage
;
Analgesics/metabolism
;
Analgesics/pharmacology*
;
Animals
;
Atropine/metabolism
;
Dihydroergocristine/metabolism
;
Enzyme Inhibitors/metabolism
;
Excitatory Amino Acid Agonists/metabolism
;
GABA Antagonists/metabolism
;
Injections, Spinal
;
Leucine/metabolism
;
Male
;
Mecamylamine/metabolism
;
Muscarinic Antagonists/metabolism
;
N-Methylaspartate/metabolism
;
Naloxone/metabolism
;
Narcotic Antagonists/metabolism
;
Nicotinic Antagonists/metabolism
;
Pain Measurement
;
Quinazolines/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Serine/metabolism
;
Spinal Cord/drug effects*
;
Thapsigargin/metabolism
;
Triazoles/metabolism
;
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism
9.Recent progress in the study of HIV-1 transcription factor NF-kappaB and its inhibitors.
Acta Pharmaceutica Sinica 2007;42(10):1007-1012
Human immunodeficiency virus type 1 (HIV-1) transcription is a crucial step in the viral replication cycle, which is considered to be a potential target for inhibition of HIV-1 replication. Among the factors involved in this step, the cellular protein nuclear factor NF-kappaB is the most powerful inducer of HIV-1 transcription. HIV-1 transcription is initiated by the binding of NF-kappaB to the enhancer region in the long terminal repeat (LTR) of HIV-1. Several compounds suppress HIV-1 transcription through the inhibition of NF-kappaB activation. The mechanisms of NF-kappaB in the transcription of HIV-1 and progress of the current inhibitors of NF-kappaB are reviewed.
Anti-HIV Agents
;
pharmacology
;
HIV Long Terminal Repeat
;
HIV-1
;
genetics
;
Humans
;
I-kappa B Kinase
;
metabolism
;
I-kappa B Proteins
;
metabolism
;
NF-KappaB Inhibitor alpha
;
NF-kappa B
;
antagonists & inhibitors
;
metabolism
;
Nicotinic Acids
;
pharmacology
;
Nitriles
;
pharmacology
;
Transcription, Genetic
;
drug effects
;
Virus Replication
10.Inhibition of ACh on the delayed rectifier-like potassium current in acutely isolated cerebral cortical neurons of rats.
Lan-Wei CUI ; Yu-Rong LI ; Lei YANG ; Shu-Wei JIA ; Li-Hui QU ; Kun YAO ; Hong-Bo JIN
Acta Physiologica Sinica 2006;58(1):58-64
The modulation of ACh on delayed rectifier-like potassium currents (I(K)) was studied in freshly dissociated cerebral cortical neurons using the whole-cell patch-clamp technique. Wistar rats between 10- and 14-day old of both sexes were used. After rats were decapitated, their brains were quickly removed, iced, and then manually cut into 400 mum slices. Slices were then incubated for 0.5 h at 32 degrees C in a buffered artificial cerebrospinal fluid (ACSF) bubbled with 95% O2, 5% CO2. Slices were then removed into buffered ACSF containing protease (0.5 mg/ml) at 32 degrees C. After 30 min of enzyme digestion, tissue was rinsed three times in the buffered saline. Then the enzyme-treated slices were mechanically dissociated with a graded series of fire-polished Pasteur pipettes. The cell suspension was then plated into a 35 mm dish and placed on the stage of a Olympus inverted microscope. For whole-cell recordings of currents, standard voltage-clamp techniques were used. Neurons were held at -80 mV, and the I(K) was evoked by 2 000 ms depolarizing voltage commands to potential between -40 mV and +60 mV in 10 mV steps applied at a frequency of 0.5 Hz. It was found that the inhibitory effect of ACh (0.1, 1, 10, 100 mumol/L) on I(K) was dose-dependent. It was also found that ACh affected the activation process of I(K) significantly, i.e., the activation curve of I(K) was characterized by half-activation potential of (-41.8+/-9.7) mV and a slope factor of (30.7+/-7.2) mV in the cortical neurons and they were changed to (-122.4+/-38.6) mV and (42.4+/-7.0) mV, respectively, after giving ACh (10 mumol/L). Tubocurarine (100 mumol/L) antagonized the inhibitory effect of ACh on I(K), and the drop of currents varied from the control value of (36.5+/-7..8)% to (16.9+/-13.8)% (n=8, P<0.01). 4-DAMP (10 mumol/L) blocked the inhibitory effect of ACh on I(K), and the currents reduced from the control value of (36.5+/-7.8)% to (26.8+/-4.7) % (n=6, P<0.05). Pirenzepin did not antagonize the inhibition of ACh on I(K) (n=7, P>0.05). Chelerythrine (20 mumol/L) blocked the inhibitory effect of ACh on I(K) and the currents reduced from the control value of (36.5+/-7.8)% to (11.7+/-17.3)% (n=6, P<0.05). On the contrary, PDBu (10 mumol/L) strengthened the inhibition of ACh on I(K) and the drop of currents changed from the control value of (36.5+/-7.8)% to (59.2+/-14.0)% (n=5, P<0.05). PDBu abolished the antagonism of chelerythrine on ACh in cortical neurons. It is suggested that the ACh-induced depolarization of neurons in the cortex is attributed to the inhibition of I(K) that is most likely evoked by the activation of nicotinic ACh receptors and muscarinic M3 receptor via protein kinase C (PKC) signal transduction pathway.
Acetylcholine
;
physiology
;
Animals
;
Cell Separation
;
Delayed Rectifier Potassium Channels
;
antagonists & inhibitors
;
Female
;
Male
;
Neurons
;
metabolism
;
physiology
;
Patch-Clamp Techniques
;
Protein Kinase C
;
metabolism
;
physiology
;
Rats
;
Rats, Wistar
;
Receptor, Muscarinic M3
;
metabolism
;
Receptors, Nicotinic
;
metabolism
;
Signal Transduction
;
physiology
;
Somatosensory Cortex
;
cytology
;
physiology